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INTRODUCTION
The concurrence of pulmonary embolism (PE) and aortic 
dissection is rare and therefore creates therapeutic dilem-
mas [1]. Anticoagulation is the cornerstone therapy for PE 
and is upgraded to systemic thrombolysis in patients with 
hemodynamic instability [2]. However, acute aortic dissec-
tion is commonly deemed a contraindication to such thera-
pies, and several investigators have reported aortic leakage 
during anticoagulation therapy in patients with aortic dis-
section [3], a lthough this concern has never been proven. 
Conversely, recent reports showed the safety of antico-
agulation in intramural hematoma and acute type B aortic 
dissection (TBAD) [1,4,5]. Moreover, contradictory evidence 
exists about the role of anticoagulation therapy on the false 
lumen patency [6,7].
We herein describe a patient with T BAD complicated by 
PE. This report will outline the safety of anticoagulation 
therapy in a patient with aortic dissection, as well as the 
role of early thoracic endovascular aortic repair (TEVAR), 
the possible interaction with anticoagulation therapy, and 
finally the effect of anticoagulation therapy on the false lu-
men patency. 
CASE
A 60-year-old man with a history of chronic obstructive 
pulmonary disease was admitted to a hospital because of 
the sudden onset of abdominal pain. No history of previ-
ously known cardiovascular risk factors or cardiovascu-
lar diseases was reported by the patient. Initially, he was 
treated as an outpatient with the impression of gastric 
ulcer. However, his symptoms aggravated and he returned 
to the index hospital 12 hours after his outpatient visit ow-
ing to intractable abdominal pain, episodes of syncope, 
and respiratory distress necessitating intubation. A bedside 
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ultrasound examination revealed massive pleural effusion 
and abdominal aortic dissection. A computed tomography 
angiography (CTA) scan revealed a TBAD extending to the 
abdominal aorta (Fig. 1). The patient’s syncope and respira-
tory distress were attributed to the TBAD and the concomi-
tant pleural effusion. The TBAD was classified as impend-
ing to rupture, and the patient was referred to our center 
for TE VAR.
Our rapid initial evaluation via transthoracic echocar-
diography showed severe right ventricular (RV) enlarge-
ment along with moderate RV systolic dysfunction, mi d-RV 
free-wall akinesia, and normal motion at the apex (McCon-
nell sign). Left ventricular hypertrophy was also apparent, 
probably indicative of long-standing uncontrolled hyper-
tension. A pulmonary CTA confirmed intraluminal filling 
defects in both the right upper and left lower pulmonary 
lobar branches in addition to the left and right upper and 
lower pulmonary segmental and subsegmental branches, 
suggestive of acute PE (Fig. 2). A bedside Doppler venous 
ultrasound also revealed left popliteal acute deep venous 
thrombosis.
Two options were proposed for the treatment of the 
concomitant PE: deployment of an inferior vena cava filter 
or emergent TEVAR alongside anticoagulation therapy. 
Because the radiological findings were suggestive of im-
pending rupture, the decision was made to proceed with 
TEVAR (Fig. 3) [8]. Unfractionated heparin was immediately 
started, and vascular accesses (via both common femoral 
arteries) were obtained under ultrasound guidance. TEVAR 
was percutaneously commenced using vascular closure de-
vices (Perclose ProGlide; Abbott Vascular Devices, Redwood 
City, CA, USA). The right radial access was obtained for aor-
tic root injection and device positioning, and the left radial 
access was used for coil delivering. For the prevention of 
spinal cord ischemia, a single 36×40×217 mm Zenith Alpha 
Thoracic Endovascular Graft (Cook Medical, Bloomington, 
IN, USA) was implanted just after the left carotid artery and 
above the celiac artery, covering the entry site. Ra pid RV 
pacing was applied for correct endograft deployment.
In our patient, for the prevention of future type II en-
doleak, 3 Nester co ils (Cook Medical) were deployed via the 
left radial access into the insertion of the subclavian artery. 
After the termination of TEVAR, a pigtail catheter was in-
serted for the drainage of the patient’s massive hemotho-
rax.
Given the patient’s concomitant RV dysfunction and 
history of chronic obstructive pulmonary disease, weaning 
from the ventilator was delicately performed in a stepwise 
manner. The control CTA was satisfactory in terms of the 
endovascular procedure and proper device positioning (Fig. 
4). However, a small type II endoleak from the left subcla-
vian artery was detected, for which a conservative approach 
was decided. After 15 days, the patient was discharged from 
the hospital in good condition on warfarin with an inter-
A B
 Fig. 1. Three-dimensional re-
constructed computed tomog-
raphy images showing a type B 
aortic dissection, starting just at 
the origin of the left subclavian 
artery (A) and extending down 
to the left common iliac artery 
(B). All visceral vessels are sepa-
rated from the true lumen (B).
Fig. 2.  Computed tomography angiography image showing 
acute pulmonary embolism in the left and right lobar arter-





national normalized ratio of 2 to 3. At the 6-month follow-
up, a CTA scan showed reduced size of the false lumen with 
nearly complete thrombosis (Fig. 5). Apart from the index 
event, our patient did not mention any history of previous 
venous thromboembolism. Consequently, we stopped an-
ticoagulation after the 6-month therapy. The RV function 
was preserved in the follow-up echocardiography.
DISCUSSION
Trad itionally, conservative management has been of-
fered as the main therapeutic strategy for TBAD, with TE-
VAR being reserved for complicated cases such as hemody-
namic instability, malperfusion, uncontrolled hypertension, 
and intractable pain [9]. Nevertheless, several reports have 
shown that >40% of initially uncomplicated TBAD cases 
will be complicated during their courses and, consequently, 
early TEVAR may be a rational solution in high-risk pa-
tients [10]. Several indices have been suggested as predic-
tors of late complications, the most significant of which are 
entry tear >10 mm, total aortic diameter >40 mm, and false 
lumen diameter >20 mm [8]. All these radiological indices 
were positively identified in our patient, prompting us to 
opt for a more invasive management (Fig. 3).
In addition to TBAD, our patient was complicated by 
another critical condition: PE. Classically, acute aortic dis-
A B
Fig. 4.  Computed tomography 
angiography images obtained 
after thoracic endovascular 
aortic repair. (A) The endograft 
was deployed just distal to the 
origin of the left carotid artery. 
(B) The endograft was properly 






Fig. 3. Radiological predictors 
of late complications in type B 
aortic dissection. (A) Total aor-
tic diameter >40 mm and false 
lumen diameter >20 mm. (B) 
Entry tear >10 mm.
Fig. 5. Follow-up computed tomography angiography scan 
obtained at 6 months after thoracic endovascular aortic re-
pair showing decreased false lumen diameter from 29 to 20 





section has been considered a contraindication to throm-
bolytic therapy, and anticoagulation has been judged too 
risky based on the notion that it increases the risk of aortic 
rupture or massive bleeding. Hence, the combination of 
acute aortic rupture and PE, albeit rare, presents a daunt-
ing challenge [1]. Our patient’s PE may have played a role 
in aggravating his respiratory symptoms at the initial hos-
pitalization. Nonetheless, although he was intubated upon 
admission to our hospital, the fact that he had a stable 
blood pressure precluded prioritizing thrombolytic therapy. 
In any case, all available guidelines stipulate that immedi-
ate anticoagulation is of utmost importance in similar cir-
cumstances [2]. Al-Zu abi et al. [3] reported an aggravating 
aortic leak after the start of anticoagulation therapy in a 
patient with concomitant aortic dissection and PE. How-
ever, the association between anticoagulation therapy and 
bleeding risk has never been proven. Cañadas et al. [11] re-
ported no increase in bleeding complications in 3 patients 
with acute intramural hematoma, in whom anticoagulation 
was indicated for PE or atrial fibrillation. Importantly, an-
ticoagulation therapy does not seem to influence the mor-
phological course of intramural hematoma. Apart from the 
safety of anticoagulation in intramural hematoma, several 
reports have demonstrated its safety in patients complicat-
ed by aortic dissection. Mitu et al. [1] reported no bleeding 
events after the initiation of anticoagulation in a patient 
with TBAD complicated by PE. Similar results on the safety 
of anticoagulation in TBAD were reported by Bocchino et 
al. [4], who described a patient with TBAD complicated by 
acute left ventricular thrombosis necessitating anticoagu-
lation therapy. The existing literature contains no reports 
of bleeding events or dissection-related complications [4]. 
Further in this regard, von Kodolitsch et al. [5] confirmed 
the safety of anticoagulation in repaired acute type A aor-
tic dissection. 
Another important concern with respect to anticoagula-
tion therapy in acute dissection is its possible influence on 
the false lumen patency [12]. A patent false lumen has been 
related to a poor long-term prognosis [12]. However, recent 
reports have shown no impact or beneficial effects of anti-
coagulation therapy on false lumen remodeling [6,7]. Song 
et al. [6], in their series of 136 patients with acute DeBakey 
type I aortic dissection, showed that the mean segmental 
aortic growth rate was less in the anticoagulation group 
than in the no-anticoagulation group (2.9±1.3 vs. 4.5±2.8 
mm/y; P=0.0184), and concluded that early anticoagulation 
therapy may have a beneficial impact on the thrombosis 
extension, rate of aortic growth, and long-term survival. 
It should be noted that aortic pulsation may result in de-
vice displacement during deployment and the induction of 
hypotension may not only be ineffective but may also have 
deleterious effects on the patient’s condition. However, 
rapid RV pacing may prove to be effective with the fewest 
complications [13]. Careful positioning of the temporary RV 
pacing lead, especially in patients with RV dysfunction, is 
mandatory. Moreover, the RV function should be protected 
against further compromise by ensuring that the pacing is 
brief and the RV pacing lead is immediately removed after 
device positioning [13].
One of the therapeutic options that we considered for 
our patient was the implantation of an inferior vena cava 
filter. In the absence of any conclusive evidence in the lit-
erature about a superior strategy, we ultimately opted for 
TEVAR considering that it was indicated by the presence 
of the radiological predictors of late complications, with a 
view to preventing possible bleeding events such as rupture 
and leakage.
As mentioned above, our patient had all the radiological 
predictors indicating a late TBAD complication. Nonethe-
less, in patients without these predictors, the safe option is 
again anticoagulation therapy because it is associated with 
a lower risk of aortic rupture/leakage. To our knowledge, 
all of the above-mentioned studies on the safety of anti-
coagulation therapy in TBAD were conducted in patients 
who were medically managed, which again underscores the 
safety of the mentioned strategy [2,4]. 
In conclusion, a patient with concomitant TBAD and PE 
was successfully treated with early TEVAR and subsequent 
anticoagulation. Anticoagulation in acute aortic dissection 
was well tolerated in this case, although TEVAR contributed 
to a decrease in the false lumen pressure. Further investiga-
tions on the safety of anticoagulation therapy in patients 
with acute dissection are required to find more evidence-
based solutions.
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